Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Elotuzumab-Iberdomide-Dexamethasone Combination Therapy A... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Elotuzumab-Iberdomide-Dexamethasone Combination Therapy Activates T and NK Cells within the Immune Microenvironment of Multiple Myeloma Patients
0
Authors
Lucia Chen
•
Michael Amatangelo
9 more
•
Samir Parekh
Published
November 5, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Blood
Topics
Cancer Oncology
Immunology
Internal Medicine
Hematology
Gastroenterology
Medicine
Cancer Oncology
Immunology
Internal Medicine
Hematology
Show all topics
DOI
10.1182/blood-2024-211651
